Intensity Therapeutics to Participate in the 36th Annual Roth Conference March 17 to 19, 2024

March 14, 2024

https://www.prnewswire.com/news-releases/intensity-therapeutics-to-participate-in-the-36th-annual-roth-conference-march-17-to-19-2024-302088967.html

SHELTON, Conn., March 14, 2024 /PRNewswire/ — Intensity Therapeutics, Inc. (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, announces that Lewis H. Bender, Founder, President and Chief Executive Officer, will participate in a fireside chat with Roth Managing Director and Senior Analyst, Jonathan Aschoff, Ph.D. at the 36th Annual Roth Conference in Orange County, CA on Tuesday, March 19, at 12:30PM PDT at the Ritz Carlton in Laguana Nigel, CA in the Healthcare Suite 2022.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.